Analyst Ratings for Gain Therapeutics (GANX)
GANX Rating Summary
GANX Price Target Summary
- Highest: $10.00 (Roth/MKM)
- Lowest: $7.00 (Maxim Group)
- Average: $8.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$8.50 (+178.7%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
Rating Score: 8.8 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/7/2025 | Scotiabank | Louise Chen | New Coverage | Sector Outperform (N/A) |
12.00 (N/A) |
1.80 (3.05) |
69.44% | Details |
| 12/6/2024 | Roth/MKM » Updated 12/22/2025 |
Boobalan Pachaiyappan | New Coverage | Buy (N/A) |
10.00 (6.00) |
1.84 (3.05) |
65.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
